Radiopharm Theranostics (RADX) Non-Current Assets (2024 - 2025)

Radiopharm Theranostics (RADX) has disclosed Non-Current Assets for 2 consecutive years, with $46.6 million as the latest value for Q2 2025.

  • On a quarterly basis, Non-Current Assets fell 5.2% to $46.6 million in Q2 2025 year-over-year; TTM through Jun 2025 was $46.6 million, a 5.2% decrease, with the full-year FY2025 number at $46.6 million, down 5.2% from a year prior.
  • Non-Current Assets was $46.6 million for Q2 2025 at Radiopharm Theranostics, down from $49.2 million in the prior quarter.
  • In the past five years, Non-Current Assets ranged from a high of $49.2 million in Q2 2024 to a low of $46.6 million in Q2 2025.